Cite
A ferroptosis-reinforced nanocatalyst enhances chemodynamic therapy through dual H2O2 production and oxidative stress amplification.
MLA
Zhu, Xiao-Yu, et al. “A Ferroptosis-Reinforced Nanocatalyst Enhances Chemodynamic Therapy through Dual H2O2 Production and Oxidative Stress Amplification.” Journal of Controlled Release, vol. 367, Mar. 2024, pp. 892–904. EBSCOhost, https://doi.org/10.1016/j.jconrel.2024.01.049.
APA
Zhu, X.-Y., Wang, T.-Y., Jia, H.-R., Wu, S.-Y., Gao, C.-Z., Li, Y.-H., Zhang, X., Shan, B.-H., & Wu, F.-G. (2024). A ferroptosis-reinforced nanocatalyst enhances chemodynamic therapy through dual H2O2 production and oxidative stress amplification. Journal of Controlled Release, 367, 892–904. https://doi.org/10.1016/j.jconrel.2024.01.049
Chicago
Zhu, Xiao-Yu, Tian-Yu Wang, Hao-Ran Jia, Shun-Yu Wu, Cheng-Zhe Gao, Yan-Hong Li, Xinping Zhang, Bai-Hui Shan, and Fu-Gen Wu. 2024. “A Ferroptosis-Reinforced Nanocatalyst Enhances Chemodynamic Therapy through Dual H2O2 Production and Oxidative Stress Amplification.” Journal of Controlled Release 367 (March): 892–904. doi:10.1016/j.jconrel.2024.01.049.